Shorter antibiotic course non inferior for UTI recurrence in kids
Five days of oral antibiotic treatment for febrile urinary tract infections (UTIs) in kids was noninferior to the standard 10-day course, the randomized controlled STOP trial showed.
Five days of oral antibiotic treatment for febrile urinary tract infections (UTIs) in kids was noninferior to the standard 10-day course, the randomized controlled STOP trial showed.
“On a national level, hospitalizations are increasing for COVID-19; they’re up about 51% over the last four weeks or so,” said Dr. Shirin Mazumder, infectious diseases physician at Methodist Le Bonheur Healthcare.
Published results showed spinal and general anesthesia were associated with high rates of successful same-day discharge among patients who underwent outpatient total joint arthroplasty at a free-standing ASC. Tyler E. Calkins, MD, and colleagues from the University of Tennessee Health Science Center performed a matched cohort study of data from 105 patients who underwent outpatient TJA with… Read More
The Department of Audiology and Speech Pathology at the University of Tennessee Health Science Center and the Department of Hearing and Speech Sciences at Vanderbilt University have secured a $2,399,454 grant to fund a five-year project to address the need for diversity in highly trained professionals in speech-language pathology.
The University of Tennessee Research Foundation (UTRF) celebrated the researchers whose achievements are making life better locally, nationally, and globally at its annual Innovation Awards ceremony, held December 14 at the Mooney Library at the University of Tennessee Health Science Center (UTHSC) in Memphis.
At the 2023 UTHSC Impact Awards, the Office of Inclusion, Equity and Diversity recognized faculty, staff, students and trainees for outstanding work at the University of Tennessee Health Sciences Center.
The University of Tennessee Health Science Center College of Pharmacy and Tusculum University have signed a memorandum of understanding to help students complete a bachelor’s degree at Tusculum and enroll in the UTHSC College of Pharmacy Doctor of Pharmacy (PharmD) program.
Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), announced that effective today, Marko Radic PhD, has joined the Nexcella Scientific Advisory Board. Dr. Radic brings decades of experience in autoimmune cell therapy, and thought leadership to Nexcella.